# Study Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated Influenza

> **NCT05093998** · PHASE3 · UNKNOWN · sponsor: **Viriom** · enrollment: 700 (estimated)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** AV5080
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05093998
- **Lead sponsor:** Viriom
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-15
- **Primary completion:** 2023-07-15
- **Final completion:** 2023-07-31
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2021-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05093998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05093998, "Study Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated Influenza". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05093998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*